InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,967.23
(
-0.88%
)
US TECH 100
16,556.80
(
-2.24%
)
Dow Jones
37,986.40
(
0.56%
)
Brent Oil
86.63
(
0.00%
)
Bitcoin
63,860.21
(
0.05%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Rhew123

Send PM Follow Ignore
Followers 7
Posts 1487
Boards Moderated 0
Alias Born 06/05/2016

Rhew123

Re: biotech_researcher post# 257

Wednesday, 03/15/2017 10:29:55 AM

Wednesday, March 15, 2017 10:29:55 AM

Post# of 438
I believe that they said a good chunk of it was Entyce due to the delay... but that that inventory would still be usable once it can start shipping... as well as Galliprant inventory value adjustment due to market value terms agreed upon with Elanco.

I think they have a bit of a runway on cash... on average spending $14 mil per quarter "operating burn" - that will be a bit higher due to full sales team however - but with $88 million in cash, that's a bit of room...

4th quarter '17 will need to be solid for sure!

Everything I post is my opinion and only my opinion - if you read enough of my posts, you'll probably realize it's not an opinion that you'd like to take as advice or a recommendation. You've been warned.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up